Biotech debt fund breaches $1bn

By Daniel Lanyon on 13th April 2018

Alternative Credit

The investment trust has just raised a further $163.8m making it one of the largest private debt funds listed on the London market.

Biotech debt fund breaches $1bn

Biopharma Credit has raised $163.8m through a new C share issue.

The new raise comes from several institutional backers including $32.25m from Invesco and $5.52m from M&G.

Biopharma Credit, an investment trust in the fast growing private debt space, originally targeted up to $300m. Whilst the fundraise was below target, it is a good result owing to a tougher fundraising environment in 2018 so far, say analysts at Numis Securities.

”We believe this is a good result for Biopharma Credit, despite a target of up to $300m. The fundraising environment has been tough in 2018, and most fundraisings have struggled to reach targets or have been pulled. Investors are typically more willing to back what they already own, demonstrated by Invesco’s commitment,” Numis said.

Biopharma Credit market cap has, as a result of the C Share fundraise, increased to $1.1bn.

Targeting a yield of 7 per cent when fully invested, with a total return of 8-9 per cent, it raised $423.3m at IPO in March 2017. In December 2017 it raised a further $154m via a placing at a 1.5 per cent premium to its net asset value [NAV].


AltFi Amsterdam Summit 2018

AltFi is returning to Amsterdam for its second annual Summit in the city. The inaugural event last year was a roaring success, with key figures from across Continental Europe's alternative finance and digital banking sectors highlighted. These included Jeroen Broekema, managing director of Funding Circle Netherlands, and Mieke van Engelen, head of innovative partnerships at ABN AMRO's standalone lending platform, New10.

5th November 2018

More like this:

Family office seeds new private credit firm

11th September 2018
Daniel Lanyon

Funding Circle fund's returns slow in August

17th September 2018
Daniel Lanyon

Private debt market grows to record size

7th February 2018
Daniel Lanyon

P2P fund sees best 2018 month of returns

3rd September 2018
Daniel Lanyon